Dalpiciclib benefits patients with HR-positive, HER2-negative advanced breast cancer Presented ByProf. Binghe Xu, Chinese Academy of Medical Sciences and Peking Union Medical College, China TrialPhase 3, DAWNA-1 ConferenceASCO 2021 12 August, 2021 20:52
